NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Thursday reported a loss of $16.8 million in its first quarter.

On a per-share basis, the New York-based company said it had a loss of 19 cents.

The biopharmaceutical company posted revenue of $6.2 million in the period.

The company's shares closed at $3.86. A year ago, they were trading at $5.47.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNX at https://www.zacks.com/ap/PGNX

Automated Insights, source Associated Press News